<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-XVYW49R0</identifier><date>2016</date><creator>Štuhec, Matej</creator><relation>documents/doc/X/URN_NBN_SI_doc-XVYW49R0_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-XVYW49R0_001.txt</relation><format format_type="issue">1/2</format><format format_type="volume">6</format><format format_type="type">article</format><format format_type="extent">str. 37-43</format><identifier identifier_type="COBISSID">14712627</identifier><identifier identifier_type="ISSN">2232-416X</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-XVYW49R0</identifier><language>slv</language><publisher publisher_location="Murska Sobota">PAZU</publisher><source>Anali PAZU</source><rights>BY-NC-ND</rights><subject language_type_id="slv">epidemiologija</subject><subject language_type_id="eng">epidemiology</subject><subject language_type_id="slv">farmakoterapija</subject><subject language_type_id="slv">metaanalize</subject><subject language_type_id="eng">meta-analyses</subject><subject language_type_id="slv">motnja pozornosti s hiperaktivnostjo</subject><subject language_type_id="eng">pharmacoepidemiology</subject><subject language_type_id="eng">pharmacotherapy</subject><title>Epidemiologija, farmakoepidemiologija ter primerjalna učinkovitost in sprejemljivost zdravil za zdravljenje hiperkinetične motnje otrok in mladostnikov</title><title>Epidemiology, pharmacoepidemiology, comparative efficacy and acceptability of drugs in treatment of attention deficit hyperactivity disorder in children and adolescents</title></Record>